Tools

LEADER 02228cam 2200481 a 4500

001 ocm22873427;

003 OCoLC;

005 20141212044044.0;

008 910613s1990 dcu b f000 0 eng c;

010 a| 90602892;

029 1 a| AU@b| 000007931474;

035 a| (Sirsi) o22873427;

035 a| (OCoLC)22873427;

043 a| n-us---;

049 a| ERE#;

050 00 a| KF27b| .E553 1990p;

074 a| 1019-A, 1019-B (MF);

086 0 a| Y 4.En 2/3:101-164;

245 10 a| Penalties for illegal activities in the approval of drugs :b| hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House and Representatives, One Hundred First Congress, second session, on H.R. 4810 ... June 28, 1990.;

260 a| Washington :b| U.S. G.P.O. :b| For sale by the Supt. of Docs.,Congressional Sales Office, U.S. G.P.O.,c| 1990.;

300 a| iii, 198 pages ;c| 24 cm;

336 a| text2| rdacontent;

337 a| unmediated2| rdamedia;

338 a| volume2| rdacarrier;

500 a| Distributed to some depository libraries in microfiche.;

500 a| Shipping list no.: 90-788-P.;

500 a| "Serial no. 101-164.";

500 a| Item 1019-A, 1019-B (MF);

504 a| Includes bibliographical references (p. 149-153).;

610 10 a| United States.b| Food and Drug Administration.=| ^A1253;

610 10 a| United States.b| Department of Health and Human Services.=| ^A11611;

650 0 a| Drugsx| Law and legislationz| United States.=| ^A639;

650 0 a| Pharmaceutical industryx| Corrupt practicesz| United States.=| ^A1449437;

650 0 a| Pharmacyx| Law and legislationz| United States.=| ^A3211;

994 a| C0b| ERE;

938 a| Baker and Taylorb| BTCPn| 90602892;

596 a| 1;

998 a| 2135273;

999 a| Y 4.EN 2/3:101-164w| SUDOCc| 1i| 30372015492439l| JDOSm| JOYNERr| Ys| Yt| JDOSBKu| 10/19/2009x| BOOKz| JFEDDOCSo| .STAFF. jmpl;

Penalties for illegal activities in the approval of drugs : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House and Representatives, One Hundred First Congress, second session, on H.R. 4810 ... June 28, 1990.

Author/creator	United States
Format	Book
Publication Info	Washington : U.S. G.P.O. : For sale by the Supt. of Docs.,Congressional Sales Office, U.S. G.P.O., 1990.
Description	iii, 198 pages ; 24 cm
Subjects	United States. Food and Drug Administration. United States. Department of Health and Human Services. Drugs--Generic substitution. --Law and legislation. --United States. Drugs--Law and legislation. --United States. Pharmaceutical industry--Corrupt practices. --United States. Pharmacy--Law and legislation. --United States.

General note	Distributed to some depository libraries in microfiche.
General note	Shipping list no.: 90-788-P.
General note	"Serial no. 101-164."
General note	Item 1019-A, 1019-B (MF)
Bibliography note	Includes bibliographical references (p. 149-153).
LCCN	90602892
GPO item number	1019-A, 1019-B (MF)
Govt. docs number	Y 4.En 2/3:101-164

Availability

Library	Location	Call Number	Status	Item Actions
Joyner	Fed Docs Stacks	Y 4.EN 2/3:101-164	✔ Available	Place Hold

Penalties for illegal activities in the approval of drugs : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House and Representatives, One Hundred First Congress, second session, on H.R. 4810 ... June 28, 1990.

Click here for more information about this title

Availability